RGNX insider trading
Open-market stock trades by REGENXBIO (RGNX) executives and directors: who bought or sold, how many shares, at what price and when.
RGNX insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Ciongoli Gregory Austin | director | Buy | 53,407 | $9.36 | $499.68K |
| Aug 26, 2026 | Ciongoli Gregory Austin | director | Buy | 49,196 | $9.14 | $449.71K |
| Jul 2, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell | 2,161 | $13.64 | $29.48K |
| Jul 1, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell | 36,725 | $12.86 | $472.28K |
| Jun 29, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell | 19,608 | $11.04 | $216.47K |
| May 11, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell | 15,309 | $11.02 | $168.71K |
| Mar 10, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell | 5,124 | $10.35 | $53.03K |
| Oct 9, 2025 | Simpson Curran | Chief Executive Officer | Sell | 20,811 | $12.62 | $262.63K |
| Sep 29, 2025 | Simpson Curran | Chief Executive Officer | Sell | 7,624 | $10.03 | $76.47K |
| Sep 10, 2025 | Simpson Curran | Chief Executive Officer | Sell | 7,734 | $10.02 | $77.49K |
| May 12, 2025 | Mills Kenneth T. | director | Sell | 20,602 | $7.91 | $163.05K |
- RGNX insiders bought $949.38K and sold $1.52M in open-market trades over their last 11 filings.
Updated 2026-11-05 12:51 UTC